Susquehanna Fundamental Investments, LLC Standard Biotools Inc. Transaction History

Susquehanna Fundamental Investments, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.1 - $2.06 $22,987 - $43,049	-20,898 Reduced 53.53%	18,141 $20,000
Q1 2022 May 16, 2022	SELL	$2.8 - $3.96 $164,598 - $232,788	-58,785 Reduced 60.09%	39,039 $140,000
Q4 2021 Feb 14, 2022	SELL	$3.63 - $6.13 $72,897 - $123,102	-20,082 Reduced 17.03%	97,824 $383,000
Q3 2021 Nov 15, 2021	BUY	$5.5 - $7.41 $5,005 - $6,743	910 Added 0.78%	117,906 $777,000
Q2 2021 Aug 11, 2021	BUY	$4.35 - $6.35 $423,689 - $618,490	97,400 Added 497.04%	116,996 $721,000
Q1 2021 May 17, 2021	BUY	$3.94 - $7.09 $77,208 - $138,935	19,596 New	19,596 $89,000
Q4 2020 Feb 16, 2021	SELL	$5.45 - $8.65 $88,835 - $140,995	-16,300 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$4.34 - $11.43 $70,742 - $186,309	16,300 New	16,300 $121,000

143

274M

6.7K

48.7K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $84.2M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.